false
Catalog
HRX 2024 AbstracX Library
Protocolized Atrial Fibrillation Monitoring in Str ...
Protocolized Atrial Fibrillation Monitoring in Stroke: Optimizing Practice Based on Data
Back to course
Pdf Summary
The document details the DiVERT Stroke Study, led by Dr. Dhanunjaya R. Lakkireddy, which aims to improve post-stroke cardiac monitoring for atrial fibrillation (AF) detection. The study background highlights the inconsistency in cardiac monitoring practices across 13 stroke centers and the need for standardized protocols. Data from Phase I revealed significant differences in cardiac monitoring rates between Comprehensive Stroke Centers (CSC) and Non-Comprehensive Stroke Centers (NCSC), emphasizing gaps and nonadherence to guidelines in post-stroke care.<br /><br />In Phase I, CSCs employed more insertable cardiac monitors than NCSCs, resulting in higher AF detection rates among patients monitored, compared to those not monitored. This suggests that improved monitoring protocols could enhance patient outcomes, reduce recurrent stroke risks, and ensure better adherence to treatment guidelines.<br /><br />The objective moving forward is to develop a standardized, protocolized pathway for cardiac monitoring across all institutions, to be tested in DiVERT Phase II. This phase aims to evaluate clinical outcomes before and after implementing the standardized pathway, optimizing patient care and interdisciplinary workflow to better detect AF, lead to appropriate treatment adjustments, and potentially improve quality of life.<br /><br />The conclusion asserts that structured cardiac monitoring post-stroke could increase AF detection rates, facilitate timely anticoagulation, and improve adherence to medical guidelines, ultimately enhancing patient outcomes. The study involves various medical centers and investigators nationwide, collectively striving to refine post-stroke cardiac care practices.
Keywords
DiVERT Stroke Study
post-stroke cardiac monitoring
atrial fibrillation detection
standardized protocols
Comprehensive Stroke Centers
insertable cardiac monitors
Phase I and Phase II
recurrent stroke risks
interdisciplinary workflow
medical guidelines adherence
HRX is a Heart Rhythm Society (HRS) experience. Registered 501(c)(3). EIN: 04-2694458.
Vision:
To end death and suffering due to heart rhythm disorders.
Mission:
To Improve the care of patients by promoting research, education, and optimal health care policies and standards.
© Heart Rhythm Society
1325 G Street NW, Suite 500
Washington, DC 20005
×
Please select your language
1
English